Orchid Cellmark

SNP, microfluidics, robotics, develops and commercialises genetic diversity technologies, products and services

Founded in 1995 as a spin-off of the Sarnoff Corporation, Orchid completed its IPO in May 2000.

Thomas A. Bologna (President & CEO)
Raymond J. Land (CFO)

George Poste (Chairman)
James Beery
Sidney M. Hecht
Thomas A. Bologna
Kenneth D. Noonan
Gordon Wasserman
Nicole S. Williams

4390 U.S. Route One
Princeton, NJ 08540
USA
Phone: +1-609-750-2200
Fax: +1-609-750-6400

SNP-IT™ primer extension is a method of isolating the precise location of the site of a suspected SNP. The inherent accuracy of DNA polymerase to determine the presence or absence of the SNP is exploited. SNP-IT can be used on platforms such as mass spectrometry, microarrays, elctropads, flow cytometry, fluorescence (polarisation), electrophoresis, HPLC or optical density.
SNPstream™ is a 25K SNPstream system is available, a 50K system is coming out soon. The system is based on a OEM robotic system for proprietary SNP-IT primer-extension scoring assays.
The SNPware™ kit comprises approximately 10 reagents to be conducted on the SNPstream system.